Search Results for ""drugs for""
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for "drugs for". Results 2521 to 2530 of 2585 total matches.
Nutritional Supplements for Age-Related Macular Degeneration Revisited
The Medical Letter on Drugs and Therapeutics • Jun 24, 2013 (Issue 1419)
The Medical Letter®
On Drugs and Therapeutics
Volume 55 (Issue 1419)
June 24, 2013
Published ...
The results of the Age-Related Eye Disease Study 2
(AREDS2) have now been published. The primary purpose
of the study was to evaluate the efficacy and safety
of the carotenoids lutein and zeaxanthin and the
omega-3 polyunsaturated fatty acids (PUFAs) docosahexaenoic
acid (DHA) and eicosapentaenoic acid (EPA)
in reducing the risk of developing advanced age-related
macular degeneration (AMD). A secondary goal was to
test the effects of reducing the amount of zinc and eliminating
beta carotene from the original AREDS formulation.
Beta carotene has been shown to increase the
risk of...
Belotero Balance for Wrinkles and Folds
The Medical Letter on Drugs and Therapeutics • Oct 28, 2013 (Issue 1428)
The Medical Letter®
On Drugs and Therapeutics
Volume 55 (Issue 1428)
October 28, 2013
Published ...
Belotero Balance (Merz), an injectable hyaluronic acid
dermal filler, has been approved by the FDA for temporary
correction of moderate-to-severe facial wrinkles
and folds. Several other hyaluronic acid products are
also available for this indication (e.g., Restylane,
Perlane, Juvéderm). They have supplanted bovine collagen
products, which persist for a shorter time and
cause more allergic reactions.
Expanded Table: Antibiotics for Travelers' Diarrhea (online only)
The Medical Letter on Drugs and Therapeutics • Oct 07, 2019 (Issue 1582)
. www.fdbhealth.com/policies/drug-pricing-policy.
3. Not FDA-approved for treatment of travelers’ diarrhea.
4 ...
View the Expanded Table: Antibiotics for Travelers' Diarrhea
In Brief: Phesgo - A Fixed-Dose Combination for HER-2 Positive Breast Cancer (online only)
The Medical Letter on Drugs and Therapeutics • Mar 16, 2021 (Issue 1619)
with permission by First Databank, Inc. All rights
reserved. ©2021. www.fdbhealth.com/drug-pricing-policy.
1. AR ...
The FDA has approved a fixed-dose combination of
pertuzumab, trastuzumab, and hyaluronidase (Phesgo – Genentech) for use in combination with chemotherapy
for neoadjuvant (preoperative) treatment of human
epidermal growth factor receptor 2 (HER2)-positive,
locally advanced, inflammatory, or early-stage breast
cancer, or for adjuvant treatment of patients with HER2-positive early breast cancer at high risk of recurrence,
or with docetaxel for treatment of those with HER2-positive metastatic breast cancer who have not received
anti-HER2 therapy or chemotherapy for metastatic
disease....
Ryzneuta for Prevention of Febrile Neutropenia
The Medical Letter on Drugs and Therapeutics • Aug 19, 2024 (Issue 1709)
of chemotherapy-induced
febrile neutropenia. Med Lett Drugs Ther 2023; 65:83.
3. J Glaspy et al ...
Efbemalenograstim alfa-vuxw (Ryzneuta – Evive), a
nonpegylated granulocyte colony-stimulating factor
(G-CSF) conjugated to an Fc fragment of human
IgG2, has been approved by the FDA to decrease
the incidence of infection, as manifested by febrile
neutropenia, in adults with nonmyeloid malignancies
receiving myelosuppressive chemotherapy that can
cause clinically significant febrile neutropenia. It is
the first nonpegylated, long-acting G-CSF to become
available in the US. Two pegylated, long-acting
G-CSFs, pegfilgrastim (Neulasta, and biosimilars)
and eflapegrastim (Rolvedon), are...
Med Lett Drugs Ther. 2024 Aug 19;66(1709):134-5 doi:10.58347/tml.2024.1709d | Show Introduction Hide Introduction
In Brief: Afamitresgene Autoleucel (Tecelra) for Synovial Sarcoma (online only)
The Medical Letter on Drugs and Therapeutics • Oct 14, 2024 (Issue 1713)
. www.fdbhealth.com/
policies/drug-pricing-policy.
prolonged severe cytopenias, severe infection,
and secondary ...
Afamitresgene autoleucel (Tecelra – Adaptimmune),
a melanoma-associated antigen A4 (MAGE-A4)-directed genetically modified autologous T-cell
immunotherapy, has received accelerated approval
from the FDA for one-time treatment of adults with
unresectable or metastatic synovial sarcoma who
received prior chemotherapy and are HLA-A*02:01P,
-A*02:02P, -A*02:03P, or -A*02:06P positive and
whose tumor expresses the MAGE-A4 antigen. It is
the first gene therapy to be approved in the US for
treatment of synovial sarcoma. Accelerated approval
of the immunotherapy was based on the...
Med Lett Drugs Ther. 2024 Oct 14;66(1713):e169-70 doi:10.58347/tml.2024.1713i | Show Introduction Hide Introduction
Measles Revaccination
The Medical Letter on Drugs and Therapeutics • Jul 28, 1989 (Issue 797)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
In the first six months of 1989, more than 7,000 cases of measles were reported to the US Centers for Disease Control (CDC), a sharp increase over previous years (Morbid Mortal Weekly Rep, 33:456, July 7, 1989). Many of these cases occurred in children and college students who had previously been vaccinated against the disease. Practitioners have asked, therefore, whether their previously immunized young patients should receive a second (or, in some cases, third) immunization against measles.
The Reflotron For Office Chemistry
The Medical Letter on Drugs and Therapeutics • Oct 06, 1989 (Issue 802)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
The Reflotron (Boehringer Mannheim), a desk-top colorimetric reflectance analyzer that weighs 12 pounds, can do clinical chemistry tests on 30 l of whole blood, plasma or serum, using multilayered strips containing dry chemicals. A single test takes two to three minutes.
Peripheral-Blood Stem-Cells Transplants
The Medical Letter on Drugs and Therapeutics • Aug 18, 1995 (Issue 955)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
High-dose chemotherapy, with or without total body radiation, followed by bone marrow transplantation to restore bone marrow function has been used widely in the treatment of malignant diseases in recent years (Medical Letter, 34:79, 1992; 37:25, 1995). Now, however, instead of using bone marrow itself to restore function destroyed by chemotherapy and radiation, many centers infuse hematopoietic stem cells harvested from peripheral blood. Most stem cell transplants have been autologous; allogeneic stem cells have been tried in a small number of patients (WI Bensinger et al, Blood,...
Spinal Manipulation
The Medical Letter on Drugs and Therapeutics • May 27, 2002 (Issue 1131)
The Medical Letter
On Drugs and Therapeutics
www.medicalletter.org
Published by The Medical ...
Spinal manipulation has been used to treat not only back and neck pain, but also many other conditions. A recent commentary questioned its safety.